Premenstrual Syndrome Clinical Trial
Official title:
Comparison of Physical Activity Self Worth of Women With and Without Premenstrual Syndrome
Verified date | March 2023 |
Source | Nigde Omer Halisdemir University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Premenstrual syndrome (PMS) negatively affects the quality of life of millions of women. PMS is a common cyclic disorder characterized by somatic, cognitive, emotional and behavioral symptoms that usually occurs in young and middle-aged women, lasts during the luteal phase of the menstrual cycle and ends with the onset of menstruation.Studies have shown that women with high PMS symptoms are more inactive. Physical activity participation in women affects a wide spectrum of self-perceptions, including knowledge, social, and emotional self-perceptions. By determining which physical, emotional, social and academic/knowledge areas are affected by women, increasing their participation in physical activity can be achieved. The subject of the study is to determine the symptom severity of women with and without premenstrual syndrome and to examine how premenstrual syndrome affects physical activity self-worth.
Status | Completed |
Enrollment | 250 |
Est. completion date | February 28, 2023 |
Est. primary completion date | February 28, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Volunteer to participate in the study - Being 18-35 years old - Being women - To be menstruating Exclusion Criteria: - Evaluation form missing - Not menstruating for 12 months or more - Having any psychological diagnosis - Being pregnant |
Country | Name | City | State |
---|---|---|---|
Turkey | Nigde Ömer Halisdemir University | Nigde |
Lead Sponsor | Collaborator |
---|---|
Nigde Omer Halisdemir University | Ankara Yildirim Beyazit University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Descriptive Data | In the general evaluation form, data such as age, gender, weight, height, age at menarche, menstruation interval, menstrual pattern, presence of gynecological problems, presence of dysmenorrhea, pain level, exercise status, presence of chronic disease will be recorded. | Baseline | |
Primary | Premenstrual Syndrome Scale | The Premenstrual Syndrome Scale (PMSS) was developed by Gençdogan in 2006, based on DSM III and DSM-IV, and its validity and reliability were established. PMSS is a 44-item five-point Likert-type scale. After each item is read in PMSS, marking is made by taking into account the degrees to the right of the relevant item, depending on whether this situation is within the period of "one week before menstruation". In scoring the scale, "Never" is evaluated as 1, "Very little" as 2, "Sometimes" as 3, "Often" as 4, and "Constantly" as 5 points. A score of 138 or higher indicates PMS. | Baseline | |
Primary | Women's Physical Activity Self-Worth Inventory | The Women's Physical Activity Self-Worth Inventory (Women's Physical Activity Self-Worth Inventory), developed by Huberty J. et al. in 2013, is a 37-item multidimensional scale. Turkish version study, validity and reliability were done by Yutçiçek and Kömürcü in 2019. FAESQ is a 37-item Likert-type (Strongly Disagree (1), Disagree (2), Agree, (3), Strongly Agree (4)) scale that evaluates the non-physical aspects of physical activity-related self-worth in women. The total score obtained from the scale varies between 37 and 148. As the score increases, the sense of self-worth increases. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02481973 -
The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome
|
Phase 2 | |
Completed |
NCT00195559 -
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
|
Phase 3 | |
Completed |
NCT00048854 -
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00965562 -
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
|
N/A | |
Completed |
NCT05349344 -
Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).
|
N/A | |
Recruiting |
NCT06146673 -
A Multidimensional Study of Premenstrual Syndrome and Body Image
|
||
Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
Completed |
NCT05499000 -
The Effect of Emotional Freedom Technique on Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06144073 -
The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06105567 -
The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress
|
N/A | |
Completed |
NCT03298607 -
The Impact of Serelys PMS on Symptoms of PMS
|
Phase 3 | |
Recruiting |
NCT06176313 -
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
|
N/A | |
Recruiting |
NCT02562053 -
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
|
Phase 3 | |
Completed |
NCT00229346 -
Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
|
N/A | |
Completed |
NCT00516113 -
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
|
Phase 4 | |
Completed |
NCT04901598 -
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
|
||
Completed |
NCT05665972 -
Effects of Mandala Coloring on Premenstrual Syndrome
|
N/A | |
Not yet recruiting |
NCT06052722 -
The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders
|
N/A | |
Completed |
NCT05556252 -
The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life
|
N/A | |
Completed |
NCT05725447 -
Cross-cultural Adaptation, Validity and Reliability of the Turkish Version of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ)
|